Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2439
  • 2440
  • 2441
  • …
  • ›
  • »

2026-03-10

TransUnion Investor Day to Highlight Its Next Chapter of Growth – Innovation at Scale, Value that Endures

2026-03-10

Pershing Square Announces Public Filing of Registration Statements with the SEC for the Combined IPO of Pershing Square USA and Pershing Square Inc.

2026-03-10

Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026

2026-03-10

Texas-Based Restaurant Drives Kitchen Efficiency with Epson TrueOrder KDS

2026-03-10

Uranium Energy Corp Reports Results for Second Quarter of Fiscal 2026

2026-03-10

Fabrinet to Webcast Investor and Analyst Q&A Sessions at the 2026 Optical Fiber Communication Conference

2026-03-10

Edinburgh Worldwide proposes 100% tender in rebuke against Saba

2026-03-10

Spirax sees growth ahead as one-off charges dent profit in 2025

2026-03-10

Persimmon sees top-end 2026 profit as casts wary eye on events in Iran

2026-03-10

Centene to reaffirm full-year earnings guidance

2026-03-10

Esperion Therapeutics GAAP EPS of $0.22 misses by $0.05, revenue of $168.45M beats by $2.33M

2026-03-10

Foshan Chancheng District Launches Free 'Openclaw' Deployment Service for Public

  • «
  • ‹
  • …
  • 2439
  • 2440
  • 2441
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies